Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vascular Surgery

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 141 articles: HTML format

Single Articles

March 2023
1. TRUESDELL AG, Mehta A, Cilia LA
   Myocardial Infarction, Cardiogenic Shock, and Cardiac Arrest: Management Made Simple, But Not Too Simple.
   J Am Coll Cardiol. 2023;81:1177-1180.
   PubMed    
   
   
   
2. ZEYMER U, Alushi B, Noc M, Mamas MA, et al
   Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest.
   J Am Coll Cardiol. 2023;81:1165-1176.
   PubMed     Abstract available
   
   
   February 2023
3. TU S, Xu B, Chen L, Hong H, et al
   Short-Term Risk Stratification of Non-Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain.
   J Am Coll Cardiol. 2023;81:756-767.
   PubMed     Abstract available
   
   
   
4. FLATHER M, Talukder S
   Saphenous Vein Grafts for Coronary Surgery: More May Be Less.
   J Am Coll Cardiol. 2023;81:726-728.
   PubMed    
   
   
   
5. SHIH E, Squiers JJ, Banwait JK, Mack MJ, et al
   Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting.
   J Am Coll Cardiol. 2023;81:713-725.
   PubMed     Abstract available
   
   
   
6. TRUESDELL AG, Alasnag MA, Kaul P, Rab ST, et al
   Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review.
   J Am Coll Cardiol. 2023;81:590-605.
   PubMed     Abstract available
   
   
   
7. BHATT DL
   Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double?
   J Am Coll Cardiol. 2023;81:553-556.
   PubMed    
   
   
   
8. GRAGNANO F, Mehran R, Branca M, Franzone A, et al
   P2Y(12) Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
   J Am Coll Cardiol. 2023;81:537-552.
   PubMed     Abstract available
   
   
   
9. KERN KB
   Timely Reperfusion for Everyone...Except for Some Out-of-Hospital Cardiac Arrest Patients?
   J Am Coll Cardiol. 2023;81:457-459.
   PubMed    
   
   
   
10. SPIRITO A, Vaisnora L, Papadis A, Iacovelli F, et al
    Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2023;81:446-456.
    PubMed     Abstract available
    
    
    January 2023
11. LIN J, Lluri G
    Thromboprophylaxis in the Fontan Circulation: Long-Awaited Validation.
    J Am Coll Cardiol. 2023;81:390-393.
    PubMed    
    
    
    
12. VAN DEN EYNDE J, Possner M, Alahdab F, Veldtman G, et al
    Thromboprophylaxis in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:374-389.
    PubMed     Abstract available
    
    
    
13. BONACA MP, Hogan SE
    Tradeoffs in Approach to PAD Revascularization: Shared Decision Making in the Spotlight.
    J Am Coll Cardiol. 2023;81:371-373.
    PubMed    
    
    
    
14. FARHAN S, Enzmann FK, Bjorkman P, Kamran H, et al
    Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease.
    J Am Coll Cardiol. 2023;81:358-370.
    PubMed     Abstract available
    
    
    
15. FELDMAN DN, Klein AJP
    Drug-Coated Balloons in Peripheral Vascular Interventions: Leave No Trace and Walk Away?
    J Am Coll Cardiol. 2023;81:250-252.
    PubMed    
    
    
    
16. SHISHEHBOR MH, Scheinert D, Jain A, Brodmann M, et al
    Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
    J Am Coll Cardiol. 2023;81:237-249.
    PubMed     Abstract available
    
    
    
17. DHAUN N, Pugh D, Youngstein T
    Percutaneous Intervention in Takayasu Arteritis: Potential Advantages of Procedural Perseverance.
    J Am Coll Cardiol. 2023;81:65-67.
    PubMed    
    
    
    
18. JOSEPH G, Thomson VS, Attumalil TV, Mathen PG, et al
    Outcomes of Percutaneous Intervention in Patients With Takayasu Arteritis.
    J Am Coll Cardiol. 2023;81:49-64.
    PubMed     Abstract available
    
    
    November 2022
19. SONG L, Xu B, Tu S, Guan C, et al
    2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
    J Am Coll Cardiol. 2022;80:2089-2101.
    PubMed     Abstract available
    
    
    
20. DAVIDSON LJ, Cleveland JC, Welt FG, Anwaruddin S, et al
    A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2119-2134.
    PubMed     Abstract available
    
    
    
21. ROYSE A, Ren J, Royse C, Tian DH, et al
    Coronary Artery Bypass Surgery Without Saphenous Vein Grafting: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:1833-1843.
    PubMed     Abstract available
    
    
    
22. TARDIF JC, Thorin E
    Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1815-1817.
    PubMed    
    
    
    
23. NICHOL G, West A
    Contemporary Approaches to Reducing Morbidity and Mortality in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1799-1801.
    PubMed    
    
    
    
24. GONG W, Yan Y, Wang X, Zheng W, et al
    Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1788-1798.
    PubMed     Abstract available
    
    
    
25. KORJIAN S, Yeh RW, Cutlip DE
    Ischemic Risk Prediction Scores: Practice-Changing or Just Practice?
    J Am Coll Cardiol. 2022;80:1748-1750.
    PubMed    
    
    
    
26. BATRA G, Lindback J, Becker RC, Harrington RA, et al
    Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1735-1747.
    PubMed     Abstract available
    
    
    October 2022
27. BOHME M, Desch S, Rosolowski M, Scholz M, et al
    Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1545-1556.
    PubMed     Abstract available
    
    
    September 2022
28. JIN Z, Xu B, Yang X, Jia R, et al
    Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.
    J Am Coll Cardiol. 2022;80:1254-1264.
    PubMed     Abstract available
    
    
    
29. SATTAR Y, Aronow HD, Alam M
    Drug-Coated Balloon Failure Following Femoro-Popliteal Intervention: Where to Draw the Line?
    J Am Coll Cardiol. 2022;80:1251-1253.
    PubMed    
    
    
    
30. KRISHNAN P, Farhan S, Schneider P, Kamran H, et al
    Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
    J Am Coll Cardiol. 2022;80:1241-1250.
    PubMed     Abstract available
    
    
    
31. KINLAY S
    Post-PCI Antithrombotic Treatment With High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1238-1240.
    PubMed    
    
    
    
32. SMITS PC, Frigoli E, Vranckx P, Ozaki Y, et al
    Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1220-1237.
    PubMed     Abstract available
    
    
    August 2022
33. FAGUNDES A JR, Morrow DA, Oyama K, Furtado RHM, et al
    Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.
    J Am Coll Cardiol. 2022;80:887-897.
    PubMed     Abstract available
    
    
    
34. STAHLI BE, Klingenberg R, Heg D, Branca M, et al
    Randomized Trial of Early mTOR Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)06613.
    PubMed     Abstract available
    
    
    
35. OUZOUNIAN M, Tadros RO, Svensson LG, Lyden SP, et al
    Thoracoabdominal Aortic Disease and Repair: JACC Focus Seminar, Part 3.
    J Am Coll Cardiol. 2022;80:845-856.
    PubMed     Abstract available
    
    
    
36. HENSLEY SE, Upchurch GR Jr
    Repair of Abdominal Aortic Aneurysms: JACC Focus Seminar, Part 1.
    J Am Coll Cardiol. 2022;80:821-831.
    PubMed     Abstract available
    
    
    
37. VALGIMIGLI M, Frigoli E, Vranckx P, Ozaki Y, et al
    Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2022;80:766-778.
    PubMed     Abstract available
    
    
    July 2022
38. GIUSTINO G, Colombo A, Camaj A, Yasumura K, et al
    Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:348-372.
    PubMed     Abstract available
    
    
    June 2022
39. EVANGELISTA A, Pineda V, Guala A, Bijnens B, et al
    False Lumen Flow Assessment by Magnetic Resonance Imaging and Long-Term Outcomes in Uncomplicated Aortic Dissection.
    J Am Coll Cardiol. 2022;79:2415-2427.
    PubMed     Abstract available
    
    
    
40. VERDOIA M, Gioscia R, Rognoni A
    Updates on the Management of STEMI in 2021: Beyond COVID-19.
    J Am Coll Cardiol. 2022;79:2245-2246.
    PubMed    
    
    
    
41. GARCIA S, Dehghani P, Stanberry L, Grines C, et al
    Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19.
    J Am Coll Cardiol. 2022;79:2236-2244.
    PubMed     Abstract available
    
    
    May 2022
42. RAJKUMAR CA, Wereski R, Parsonage W, Cullen L, et al
    Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2022;79:2185-2187.
    PubMed    
    
    
    
43. DORFMAN AL, Del Nido PJ
    The Right Ventricle and Tricuspid Valve in Fontan Failure: A Role for Early Surgical Management.
    J Am Coll Cardiol. 2022;79:1846-1848.
    PubMed    
    
    
    
44. KING G, Buratto E, Celermajer DS, Grigg L, et al
    Natural and Modified History of Atrioventricular Valve Regurgitation in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2022;79:1832-1845.
    PubMed     Abstract available
    
    
    
45. SHERRID MV, Massera D, Swistel DG
    Surgical Septal Myectomy and Alcohol Ablation: Not Equivalent in Efficacy or Survival.
    J Am Coll Cardiol. 2022;79:1656-1659.
    PubMed    
    
    
    
46. CUI H, Schaff HV, Wang S, Lahr BD, et al
    Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1647-1655.
    PubMed     Abstract available
    
    
    April 2022
47. OLIN JW, Johnston-Cox H
    Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis: An Uncommon Treatment for an Uncommon Disease.
    J Am Coll Cardiol. 2022;79:1489-1491.
    PubMed    
    
    
    
48. ZHOU YP, Wei YP, Yang YJ, Xu XQ, et al
    Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension.
    J Am Coll Cardiol. 2022;79:1477-1488.
    PubMed     Abstract available
    
    
    
49. GRANGER CB, Krychtiuk KA, Gersh BJ
    Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short.
    J Am Coll Cardiol. 2022;79:1474-1476.
    PubMed    
    
    
    
50. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.
    J Am Coll Cardiol. 2022;79:1458-1473.
    PubMed     Abstract available
    
    
    
51. GAUDINO M, Di Franco A, Cao D, Giustino G, et al
    Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
    J Am Coll Cardiol. 2022;79:1407-1425.
    PubMed     Abstract available
    
    
    
52. MEHRAN R, Cao D, Vogel B
    Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
    J Am Coll Cardiol. 2022;79:1285-1287.
    PubMed    
    
    
    
53. KIM TO, Kang DY, Ahn JM, Kim SO, et al
    Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.
    J Am Coll Cardiol. 2022;79:1270-1284.
    PubMed     Abstract available
    
    
    March 2022
54. KWONG RY, Cardoso R, Jerosch-Herold M
    Quantitative CMR Perfusion in Patients After CABG: Emerging and Promising Evidence.
    J Am Coll Cardiol. 2022;79:1152-1154.
    PubMed    
    
    
    
55. WONG CCY, Yong ASC, Keech A, Ada C, et al
    Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMI.
    J Am Coll Cardiol. 2022;79:1127-1128.
    PubMed    
    
    
    
56. GOTBERG M, Berntorp K, Rylance R, Christiansen EH, et al
    5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve.
    J Am Coll Cardiol. 2022;79:965-974.
    PubMed     Abstract available
    
    
    February 2022
57. MCCARTHY CP, Januzzi JL Jr
    Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward.
    J Am Coll Cardiol. 2022;79:527-529.
    PubMed    
    
    
    
58. UEKI Y, Otsuka T, Bar S, Koskinas KC, et al
    Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
    J Am Coll Cardiol. 2022;79:513-526.
    PubMed     Abstract available
    
    
    
59. VRANCKX P, Angiolillo DJ, Valgimigli M
    Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
    J Am Coll Cardiol. 2022;79:428-431.
    PubMed    
    
    
    
60. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
    J Am Coll Cardiol. 2022;79:417-427.
    PubMed     Abstract available
    
    
    January 2022
61. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
    Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
    J Am Coll Cardiol. 2022;79:267-279.
    PubMed     Abstract available
    
    
    
62. HAN Y, Liao Z, Li Y, Zhao X, et al
    Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
    J Am Coll Cardiol. 2022;79:116-128.
    PubMed     Abstract available
    
    
    
63. LIU T, Howarth AG, Chen Y, Nair AR, et al
    Intramyocardial Hemorrhage and the "Wave Front" of Reperfusion Injury Compromising Myocardial Salvage.
    J Am Coll Cardiol. 2022;79:35-48.
    PubMed     Abstract available
    
    
    December 2021
64. GRINES CL, Marshall JJ
    Early Discharge After ST-Segment Elevation Myocardial Infarction: The Days Are Getting Shorter!
    J Am Coll Cardiol. 2021;78:2561-2562.
    PubMed    
    
    
    
65. RATHOD KS, Comer K, Casey-Gillman O, Moore L, et al
    Early Hospital Discharge Following PCI for Patients With STEMI.
    J Am Coll Cardiol. 2021;78:2550-2560.
    PubMed     Abstract available
    
    
    November 2021
66. NATHAN AS, Manandhar P, Wojdyla D, Nelson A, et al
    Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance.
    J Am Coll Cardiol. 2021;78:2213-2217.
    PubMed    
    
    
    
67. GIRI J, Fanaroff AC
    1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: The New Standard?
    J Am Coll Cardiol. 2021;78:2073-2075.
    PubMed    
    
    
    
68. HARRIS KM, Mena-Hurtado C, Arham A, Burg MM, et al
    Increasing Prevalence of Critical Limb Ischemia Hospitalizations With Distinct Mental Health Burden Among Younger Adults.
    J Am Coll Cardiol. 2021;78:2126-2128.
    PubMed    
    
    
    
69. VALGIMIGLI M, Cao D, Angiolillo DJ, Bangalore S, et al
    Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
    J Am Coll Cardiol. 2021;78:2060-2072.
    PubMed     Abstract available
    
    
    
70. PARIKH PB
    Dual Antiplatelet Duration After DES: Is it Time to Say Goodbye to 1-Year DAPT?
    J Am Coll Cardiol. 2021;78:1987-1989.
    PubMed    
    
    
    
71. DAVIDSON BP, Hodovan J, Layoun ME, Golwala H, et al
    Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia.
    J Am Coll Cardiol. 2021;78:1990-2000.
    PubMed     Abstract available
    
    
    
72. RIOUFOL G, Derimay F, Roubille F, Perret T, et al
    Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.
    J Am Coll Cardiol. 2021;78:1875-1885.
    PubMed     Abstract available
    
    
    
73. ZELLER T, Bohme T
    Antiproliferative Device Coatings: Efficacy Without Adverse Drug Effect?
    J Am Coll Cardiol. 2021;78:1779-1781.
    PubMed    
    
    
    
74. HESS CN, Patel MR, Bauersachs RM, Anand SS, et al
    Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
    J Am Coll Cardiol. 2021;78:1768-1778.
    PubMed     Abstract available
    
    
    October 2021
75. METKUS TS, Grant MC, Zwischenberger B, Higgins R, et al
    Reply: When Will We Stop Debating on the Value of TEE in CABG?
    J Am Coll Cardiol. 2021;78:e139-e140.
    PubMed    
    
    
    
76. ZHAN Y, Brovman EY, Cobey F
    When Will We Stop Debating on the Value of TEE in CABG?
    J Am Coll Cardiol. 2021;78:e137.
    PubMed    
    
    
    
77. SULLIVAN AE, Nanna MG, Wang TY, Bhatt DL, et al
    Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:1550-1563.
    PubMed     Abstract available
    
    
    
78. AN KR, de Mestral C, Tam DY, Qiu F, et al
    Surveillance Imaging Following Acute Type A Aortic Dissection.
    J Am Coll Cardiol. 2021 Oct 5. pii: S0735-1097(21)06218.
    PubMed     Abstract available
    
    
    September 2021
79. GUO MH, Vo TX, Horsthuis K, Rahmouni K, et al
    Durability of Minimally Invasive Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2021;78:1390-1391.
    PubMed    
    
    
    
80. KASTRATI A, Coughlan JJ, Ndrepepa G
    Primary PCI, Late Presenting STEMI, and the Limits of Time.
    J Am Coll Cardiol. 2021;78:1306-1308.
    PubMed    
    
    
    
81. BOUISSET F, Gerbaud E, Bataille V, Coste P, et al
    Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.
    J Am Coll Cardiol. 2021;78:1291-1305.
    PubMed     Abstract available
    
    
    
82. SQUIERS JJ, DiMaio JM
    SYNTAX Score II 2020: A Remake Worth the Price of Admission?
    J Am Coll Cardiol. 2021;78:1239-1241.
    PubMed    
    
    
    
83. HARA H, Shiomi H, van Klaveren D, Kent DM, et al
    External Validation of the SYNTAX Score II 2020.
    J Am Coll Cardiol. 2021;78:1227-1238.
    PubMed     Abstract available
    
    
    August 2021
84. WU EB, Brilakis ES, Mashayekhi K, Tsuchikane E, et al
    Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:840-853.
    PubMed     Abstract available
    
    
    
85. HSIA J, Szarek M, Anand S, Patel MR, et al
    Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.
    J Am Coll Cardiol. 2021;78:757-759.
    PubMed    
    
    
    
86. GRADY RM, Canter MW, Wan F, Shmalts AA, et al
    Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.
    J Am Coll Cardiol. 2021;78:468-477.
    PubMed     Abstract available
    
    
    July 2021
87. SERRUYS PW, Ono M, Garg S, Hara H, et al
    Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.
    J Am Coll Cardiol. 2021;78:384-407.
    PubMed     Abstract available
    
    
    
88. BRENER SJ
    Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk Analysis.
    J Am Coll Cardiol. 2021;78:230-233.
    PubMed    
    
    
    
89. SONNY A, Joseph L
    Improving CABG Mortality Further: Striving Toward Perfection.
    J Am Coll Cardiol. 2021;78:123-125.
    PubMed    
    
    
    
90. DOENST T, Bonow RO, Bhatt DL, Falk V, et al
    Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:180-188.
    PubMed     Abstract available
    
    
    
91. BODEN WE, Gersh BJ
    Defining the Proper SYNTAX for Long-Term Benefit of Myocardial Revascularization With Optimal Medical Therapy.
    J Am Coll Cardiol. 2021;78:39-41.
    PubMed    
    
    
    
92. KAWASHIMA H, Serruys PW, Ono M, Hara H, et al
    Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
    J Am Coll Cardiol. 2021;78:27-38.
    PubMed     Abstract available
    
    
    June 2021
93. ZALEWSKI PD, Tvorogova Z, Abdo A, Wawer AA, et al
    Harvesting Endothelial Cells During Routine Invasive Coronary Procedures.
    J Am Coll Cardiol. 2021;77:3136-3138.
    PubMed    
    
    
    
94. BARTHELEMY O, Rouanet S, Zeymer U, Thiele H, et al
    Reply: The Residual SYNTAX Score: A Useful Tool to Predict Outcomes in Cardiogenic Shock.
    J Am Coll Cardiol. 2021;77:2872-2873.
    PubMed    
    
    
    
95. LI X, Ni S
    Could Residual SYNTAX Score Predict the Prognosis of Patients With Cardiogenic Shock?
    J Am Coll Cardiol. 2021;77:2872.
    PubMed    
    
    
    
96. BURGESS SN, Juergens CP, Mussap CJ, Lo STH, et al
    Cardiogenic Shock, the Residual SYNTAX Score, and Prognosis: Corroborative "Real-World" Data.
    J Am Coll Cardiol. 2021;77:2871-2872.
    PubMed    
    
    
    
97. HESS CN, Fu JW, Gundrum J, Allen LaPointe NM, et al
    Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization.
    J Am Coll Cardiol. 2021;77:2867-2869.
    PubMed    
    
    
    
98. HIRA RS
    Revascularizing Complex CAD in Elderly Patients: The Coming-of-Age Story of Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2021;77:2774-2776.
    PubMed    
    
    
    
99. ONO M, Serruys PW, Hara H, Kawashima H, et al
    10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:2761-2773.
    PubMed     Abstract available
    
    
    May 2021
100. FOGEL MA
     The Fontan: "Straining" to Understand That "The Bigger They Come, The Harder They Fall".
     J Am Coll Cardiol. 2021;77:2490-2493.
     PubMed    
     
     
     
101. MEYER SL, St Clair N, Powell AJ, Geva T, et al
     Integrated Clinical and Magnetic Resonance Imaging Assessments Late After Fontan Operation.
     J Am Coll Cardiol. 2021;77:2480-2489.
     PubMed     Abstract available
     
     
     
102. ALVAREZ-FUENTE M, Ayala A, Garrido-Lestache E, Bermudez-Canete R, et al
     Long-Term Complications After Aortic Coarctation Stenting.
     J Am Coll Cardiol. 2021;77:2448-2450.
     PubMed    
     
     
     
103. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
     Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2432-2447.
     PubMed     Abstract available
     
     
     
104. MARLEVI D, Edelman ER
     Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2413-2431.
     PubMed     Abstract available
     
     
     
105. LEITER LA, Bhatt DL, McGuire DK, Teoh H, et al
     Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
     J Am Coll Cardiol. 2021;77:2366-2377.
     PubMed     Abstract available
     
     
     
106. BAUERSACHS RM, Szarek M, Brodmann M, Gudz I, et al
     Total Ischemic Event Reduction with Rivaroxaban after Peripheral Arterial Revascularization in the VOYAGER PAD Trial.
     J Am Coll Cardiol. 2021 May 7. pii: S0735-1097(21)05016.
     PubMed     Abstract available
     
     
     
107. VINCIGUERRA M, Spadaccio C, Tennyson C, Karuppannan M, et al
     Management of Patients With Aortocoronary Saphenous Vein Graft Aneurysms: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2236-2253.
     PubMed     Abstract available
     
     
     
108. FAROUX L, Lhermusier T, Vincent F, Nombela-Franco L, et al
     ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2187-2199.
     PubMed     Abstract available
     
     
     April 2021
109. METKUS TS, Thibault D, Grant MC, Badhwar V, et al
     Utilization and outcomes of transesophageal echocardiography in 1.3 million CABG procedures.
     J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04930.
     PubMed     Abstract available
     
     
     
110. CASTRO-DOMINGUEZ YS, Wang Y, Minges KE, McNamara RL, et al
     Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.
     J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04934.
     PubMed     Abstract available
     
     
     
111. GARCIA S, Dehghani P, Grines C, Davidson L, et al
     Initial Findings From the North American COVID-19 Myocardial Infarction Registry.
     J Am Coll Cardiol. 2021;77:1994-2003.
     PubMed     Abstract available
     
     
     
112. YAMMINE H, Briggs CS, Rolle QV, Ballast JK, et al
     Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair.
     J Am Coll Cardiol. 2021;77:2156-2157.
     PubMed    
     
     
     
113. TANG GHL, Tadros RO
     Endovascular Aortic Repair in Nonagenarians: Select Well and Time Appropriately.
     J Am Coll Cardiol. 2021;77:1900-1902.
     PubMed    
     
     
     
114. PRENDES CF, Dayama A, Panneton JM, Stana J, et al
     Endovascular Aortic Repair in Nonagenarian Patients.
     J Am Coll Cardiol. 2021;77:1891-1899.
     PubMed     Abstract available
     
     
     
115. CHO KH, Han X, Ahn JH, Hyun DY, et al
     Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2021;77:1859-1870.
     PubMed     Abstract available
     
     
     
116. RIDKER PM
     Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention.
     J Am Coll Cardiol. 2021;77:1856-1858.
     PubMed    
     
     
     
117. BROCH K, Anstensrud AK, Woxholt S, Sharma K, et al
     Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2021;77:1845-1855.
     PubMed     Abstract available
     
     
     
118. PERICAS JM, Llopis J, Jimenez-Exposito MJ, Kourany WM, et al
     Infective Endocarditis in Patients on Chronic Hemodialysis.
     J Am Coll Cardiol. 2021;77:1629-1640.
     PubMed     Abstract available
     
     
     March 2021
119. EGBE AC, Borlaug BA
     Reply: Abnormal Pulmonary Vascular Reserve in Fontan: Pulmonary Vascular Disease Versus Diastolic Dysfunction.
     J Am Coll Cardiol. 2021;77:1596-1597.
     PubMed    
     
     
     
120. CEDARS A, Opotowsky A, Tedford RJ, Burkhoff D, et al
     Resist Neglecting Diastolic Dysfunction in Fontan Physiology.
     J Am Coll Cardiol. 2021;77:1595-1596.
     PubMed    
     
     
     
121. LATUS H, Apitz C
     Exercise-Induced Pulmonary Hypertension: The Final Answer to Characterize Pulmonary Vascular Disease in Fontan Patients?
     J Am Coll Cardiol. 2021;77:1594-1595.
     PubMed    
     
     
     
122. SABA PS, Parodi G, Ganau A
     From Risk Factors to Clinical Disease: New Opportunities and Challenges for Cardiovascular Risk Prediction.
     J Am Coll Cardiol. 2021;77:1436-1438.
     PubMed    
     
     
     
123. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
     TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
     J Am Coll Cardiol. 2021;77:1481-1483.
     PubMed    
     
     
     
124. LLANOS-CHEA F, Jelani QU, Trejo-Paredes C, Curtis JP, et al
     Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia.
     J Am Coll Cardiol. 2021;77:1374-1375.
     PubMed    
     
     
     
125. NAKASHIMA CAK, Dallan LAO, Lisboa LAF, Jatene FB, et al
     Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.
     J Am Coll Cardiol. 2021;77:1277-1286.
     PubMed     Abstract available
     
     
     
126. CUTLIP DE
     Standing the Test of Time: A Device and Patient Perspective.
     J Am Coll Cardiol. 2021;77:1179-1181.
     PubMed    
     
     
     February 2021
127. MCCARTHY CP, Kolte D, Kennedy KF, Vaduganathan M, et al
     Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction.
     J Am Coll Cardiol. 2021;77:848-857.
     PubMed     Abstract available
     
     
     
128. KRAWISZ AK, Rosenfield K, White CJ, Jaff MR, et al
     Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.
     J Am Coll Cardiol. 2021;77:835-844.
     PubMed     Abstract available
     
     
     
129. MOSES JW, Prasad M
     Are All Total Occlusions Created Equal?: Striving for Complete Revascularization While Differentiating Apples From Oranges.
     J Am Coll Cardiol. 2021;77:541-543.
     PubMed    
     
     
     
130. KAWASHIMA H, Takahashi K, Ono M, Hara H, et al
     Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.
     J Am Coll Cardiol. 2021;77:529-540.
     PubMed     Abstract available
     
     
     
131. KODALI S, Hahn RT, Eleid MF, Kipperman R, et al
     Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:345-356.
     PubMed     Abstract available
     
     
     January 2021
132. OHMAN EM, Nanna MG
     Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?
     J Am Coll Cardiol. 2021;77:268-270.
     PubMed    
     
     
     
133. LURZ P, Stephan von Bardeleben R, Weber M, Sitges M, et al
     Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:229-239.
     PubMed     Abstract available
     
     
     
134. KOCHAR A, Varshney AS, Wang DE
     Residual SYNTAX Score After Revascularization in Cardiogenic Shock: When Is Complete Complete?
     J Am Coll Cardiol. 2021;77:156-158.
     PubMed    
     
     
     
135. BARTHELEMY O, Rouanet S, Brugier D, Vignolles N, et al
     Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
     J Am Coll Cardiol. 2021;77:144-155.
     PubMed     Abstract available
     
     
     
136. LAWTON JS
     Why Not Give All Patients the Opportunity to Have the Benefits of BITA Grafting?
     J Am Coll Cardiol. 2021;77:27-28.
     PubMed    
     
     
     
137. GOLDSTEIN BH, Kreutzer J
     Transcatheter Intervention for Congenital Defects Involving the Great Vessels: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:80-96.
     PubMed     Abstract available
     
     
     
138. WANG H, Zhang Y, Xin F, Jiang H, et al
     Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation.
     J Am Coll Cardiol. 2021;77:57-67.
     PubMed     Abstract available
     
     
     
139. GAUDINO M, Di Franco A, Flather M, Gerry S, et al
     Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial.
     J Am Coll Cardiol. 2021;77:18-26.
     PubMed     Abstract available
     
     
     December 2020
140. RAO SV, Vidovich MI, Gilchrist IC, Gulati R, et al
     2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee.
     J Am Coll Cardiol. 2020 Dec 28. pii: S0735-1097(20)37778.
     PubMed    
     
     
     November 2020
141. KUMBHANI DJ, Cannon CP, Beavers CJ, Bhatt DL, et al
     2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report
     J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)36615.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: